This annual 3-day workshop brings together 20-25 senior fellows from the leading medical oncology, surgical oncology, radiation oncology, and surgical subspecialty fellowships in the United States. For the first time, applications from junior faculty who are within 5 years of training completion will also be considered.
Chaired by Ross Donehower (Johns Hopkins) and Merrill Egorin (University of Pittsburgh), the 16-member faculty includes researchers and educators from NCI, FDA, and the nation’s leading cancer centers. The course has received national recognition for its focused and practical approach to preparing individuals to conduct cancer drug research.
The broad-based curriculum covers a range of topics related to new drug development and clinical evaluation. Expert speakers will lead discussions and present important didactic information regarding the preclinical and clinical evaluation of cytotoxic and targeted drugs, the identification and use of biomarkers, the special challenges of evaluating combination therapies, the problem of pharmacodynamic and pharmacokinetic drug interactions, and effects of organ dysfunction on drug disposition and toxicity. The discussion will include a focus on validation of targets and confirmation of mechanism of action and resistance in clinical trials. The 20-25 scholars selected will have ample opportunity for one-on-one interface with the nationally renowned faculty as well as peer-to-peer networking. Specialized evening workshops will also include sessions on new drugs, utility of biomarkers for selection of subjects and for prediction of response, and late breaking developments in cancer therapeutics.
The Foundation’s award covers expenses for tuition, course materials, lodging, and meals for fellow-level participants. Junior faculty selected for participation will be responsible for their own travel and housing.
Applicants must be currently enrolled in an accredited oncology-training program or be junior faculty within 5 years of completion of training and should have a demonstrated interest in cancer research. To apply, candidates should electronically transmit the following: a) current curriculum vitae; b) letter of recommendation from department chairman or program director including a statement that the candidate will be allocated the time off to attend this program; and c) a 1-page letter describing applicant’s purpose in attending the program, including a brief description of past/ongoing activities illustrating interest in the field. Submissions must include all three components at the time of transmission and should be directed to slisanti@cancereducationconsortium.org. No partial submission will be considered. The complete application packet must be received by June 18, 2010. Applicants will receive e-mail notification of receipt within 48 hours. For further information telephone 201-338-2537 or e-mail to: slisanti@cancereducationconsortium.org
Click on a program for more information
THE MOLECULAR AND TRANSLATIONAL ONCOLOGY WORKSHOP
PHARMACOLOGIC AND MOLECULAR BASIS OF CANCER DRUG DEVELOPMENT
In addition to these programs, The Cancer Education Consortium has a strong interest in developing programs on Pharmacoeconomics, Cancer Genetics, and Cancer Survivorship.